Stay updated on BCMA CAR T Cells ± Lenalidomide in Myeloma Clinical Trial
Sign up to get notified when there's something new on the BCMA CAR T Cells ± Lenalidomide in Myeloma Clinical Trial page.

Latest updates to the BCMA CAR T Cells ± Lenalidomide in Myeloma Clinical Trial page
- Check3 days agoChange DetectedThe update includes a minor CMS revision (Revision: v3.3.4) and related topic links (e.g., MedlinePlus Genetics) with the page emphasizing Multiple Myeloma; core trial content and enrollment criteria remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange Detected- The page now includes a Locations section showing the New York site (Memorial Sloan Kettering Cancer Center). - This adds location-specific details for the study page.SummaryDifference0.4%

- Check39 days agoChange DetectedAdded related topics: Multiple myeloma and MedlinePlus Genetics in the Related Topics section.SummaryDifference0.2%

- Check53 days agoChange DetectedAdded a PubMed auto-fill publication note and updated the page revision to v3.3.2. The previous PubMed listing explanation with a v3.2.0 revision label was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check61 days agoChange DetectedFunding-status notice was removed; this does not affect trial details or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check68 days agoChange DetectedDeleted related topics entries: 'Multiple Myeloma' and 'MedlinePlus Genetics' from the Study's related topics section. This removes explicit disease context and access to a genetics resource from the page.SummaryDifference0.2%

Stay in the know with updates to BCMA CAR T Cells ± Lenalidomide in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BCMA CAR T Cells ± Lenalidomide in Myeloma Clinical Trial page.